Catch up on this weeks cell and gene therapy news in just 5 minutes!
The FDA issued potency guidance for cell and gene therapy manufacturers and accepted uniQure’s BLA for its Huntington’s disease gene therapy for review. Plus, the MHRA approved an extension to the use of Casgevy for younger patients. Get the details in our weekly roundup >>> hubs.ly/Q04Dzf3y0
The FDA issued potency guidance for cell and gene therapy manufacturers and accepted uniQure’s BLA for its Huntington’s disease gene therapy for review. Plus, the MHRA approved an extension to the use of Casgevy for younger patients. Get the details in our weekly roundup >>> hubs.ly/Q04Dzf3y0
1
0
0
57
Discover how everyday handling and storage can trigger ice damage in cryopreserved cell therapies, and what you can do to protect them.
Register here >>> hubs.ly/Q04C2M050
Register here >>> hubs.ly/Q04C2M050
0
0
0
52
How do you overcome MSC variability to achieve reproducible, scalable results? Discover how a standardized UC-MSC source + defined expansion media can build a stronger foundation for MSC research.
Learn more >>> hubs.ly/Q04CQh590
Learn more >>> hubs.ly/Q04CQh590
0
0
0
105
Don’t miss our upcoming webinar with Miltenyi Biotec, ‘Automated HSC engineering process for HIV gene therapy: new process and preclinical data.’ Register now >>> hubs.ly/Q04BgsYw0
0
0
0
80
What's the latest in cell and gene therapy? Catch up here: hubs.ly/Q04CNTyS0
> Artiva Biotherapeutics has discontinued development of its allogeneic NK cell therapy.
>Bristol Myers Squibb presented encouraging Phase I data on Zola-cel for multiple sclerosis.
> The US Food and Drug Administration and the Centers for Medicare & Medicaid Services (CMS) issued draft guidance to help advance gene therapies.
> Artiva Biotherapeutics has discontinued development of its allogeneic NK cell therapy.
>Bristol Myers Squibb presented encouraging Phase I data on Zola-cel for multiple sclerosis.
> The US Food and Drug Administration and the Centers for Medicare & Medicaid Services (CMS) issued draft guidance to help advance gene therapies.
0
0
0
95
Could controlling ice recrystallization be the key to protecting cryopreserved cell therapies from temperature-driven damage and preserving post-thaw quality and function?
Learn more >>> hubs.ly/Q04C2LnB0
Learn more >>> hubs.ly/Q04C2LnB0
0
0
0
45
This interview gives expert guidance on cryopreservation strategy for cell therapy developers >>> hubs.ly/Q04zhdrg0
Dive into practical guidance for cell therapy developers navigating the complex intersection of cell biology, process development and regulatory requirements.
Dive into practical guidance for cell therapy developers navigating the complex intersection of cell biology, process development and regulatory requirements.
0
0
0
46
In a mouse model, researchers have demonstrated the potential of a new gene-editing approach using Cas9 nickase to transform the treatment of Huntington’s disease. Find out more here: hubs.ly/Q04CKvLn0
0
0
0
57
To celebrate 20 years of the journal Regenerative Medicine, Dusko Ilic reflects on the transformative moments that have defined regenerative medicine since 2006. Read here: hubs.ly/Q04CzdKZ0
0
2
2
174
Scalable, reproducible HSC gene therapy manufacturing matters. Join our webinar to discover lessons learned from automated processing and get new performance data and expert insights.
Join us: hubs.ly/Q04Bgsm90
Join us: hubs.ly/Q04Bgsm90
0
0
1
82
Explore our new infographic on cell therapy cryopreservation >>> hubs.ly/Q04zh8qq0
Learn about:
- how cryopreservation medium composition can affect therapeutic outcomes
- the unique vulnerabilities of different cell type
- regulatory considerations associated with reagent selection
Learn about:
- how cryopreservation medium composition can affect therapeutic outcomes
- the unique vulnerabilities of different cell type
- regulatory considerations associated with reagent selection
0
0
0
85
This application note provides a standardized workflow for the cryopreservation and recovery of cultured cells, with practical strategies to maintain cell viability and functionality throughout the freeze-thaw process >>> hubs.ly/Q04zhjrh0
0
0
0
68
In our latest In Focus feature, we're exploring cryopreservation >>> hubs.ly/Q04zh66B0
Check out our video, infographic and expert interview to explore the challenges, pitfalls and optimized strategies that can make the difference between therapeutic success and failure.
Check out our video, infographic and expert interview to explore the challenges, pitfalls and optimized strategies that can make the difference between therapeutic success and failure.
0
0
1
79
Ready to advance your HSC gene therapy production? Automated cell processing enhances quality and efficiency while helping to accelerate the delivery of gene-modified HSC therapies to patients.
Register >>> hubs.ly/Q04Bgs820
Register >>> hubs.ly/Q04Bgs820
0
0
1
49
Have you downloaded our cardiac regeneration eBook? Discover peer-reviewed content and expert insights covering human-relevant research models, innovative therapeutics, biomaterial scaffolds and translational perspectives >>> hubs.ly/Q04zT7xh0
0
0
1
56
Don’t miss our upcoming webinar with Sartorius, ‘Building compliance into every step: validation across the fill & finish workflow.’ Register now >>> hubs.ly/Q04zcmTt0
0
0
1
97
Reliable cell culture starts with standardized protocols.
This primary cell culture guide delivers step-by-step procedures for thawing, freezing and subculturing cells >>> hubs.ly/Q04zhk2Z0
This primary cell culture guide delivers step-by-step procedures for thawing, freezing and subculturing cells >>> hubs.ly/Q04zhk2Z0
0
0
0
71
Today is Stem Cell Awareness Day!
Explore recent advancements in stem cell research in regenerative medicine and examine current and emerging regenerative approaches that hold promise for enhancing treatment options.
Read here: hubs.ly/Q04B60D50
#StemCells #StemCellAwarenessDay #MSCs #iPSCs
Explore recent advancements in stem cell research in regenerative medicine and examine current and emerging regenerative approaches that hold promise for enhancing treatment options.
Read here: hubs.ly/Q04B60D50
#StemCells #StemCellAwarenessDay #MSCs #iPSCs
0
0
0
40
We're celebrating 20 years of our partner journal, Regenerative Medicine!
To mark this milestone, we're kicking off a series of specially commissioned anniversary content, starting with a retrospective article collection spanning 20 years of stem cell research! These articles of approaches within the field and celebrate the significant advances that have occurred over the journal’s lifetime.
👉 Explore the collection: hubs.ly/Q04B5-j50
Keep an eye on the anniversary homepage where we'll be sharing more retrospective content, expert interviews and exclusive features as we continue to celebrate two decades of Regenerative Medicine.
👉 Visit the anniversary homepage: hubs.ly/Q04B5-mM0
#20YearsofRegenerativeMedicine
To mark this milestone, we're kicking off a series of specially commissioned anniversary content, starting with a retrospective article collection spanning 20 years of stem cell research! These articles of approaches within the field and celebrate the significant advances that have occurred over the journal’s lifetime.
👉 Explore the collection: hubs.ly/Q04B5-j50
Keep an eye on the anniversary homepage where we'll be sharing more retrospective content, expert interviews and exclusive features as we continue to celebrate two decades of Regenerative Medicine.
👉 Visit the anniversary homepage: hubs.ly/Q04B5-mM0
#20YearsofRegenerativeMedicine
1
0
4
120
Discover why robust validation strategies are critical for ensuring compliance and minimizing risk.
Register today >>> hubs.ly/Q04zclFG0
Register today >>> hubs.ly/Q04zclFG0
0
0
0
62